Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment

Fig. 3

Characterization of SLN-BUD and SLN-BUD-2L. (A) Characterization of SLN-BUD and SLN-BUD-2L. (B) Size distribution analysis of SLN-BUD and SLN-BUD-2L by DLS. (C) TEM images of SLN-BUD and SLN-BUD-2L. (D) Size change, (E) zeta potential change, and (F) encapsulation efficiency of SLN-BUD-2L in the stability experiment at 4 and 25 °C

Back to article page